Melatonin for Huntington's Disease
Study Summary
This trial is studying how well melatonin works in improving sleep quality in people with a genetic mutation that causes Huntington's disease.
- Huntington's Disease
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 2 trial • 40 Patients • NCT01114373Trial Design
Find a site
Who is running the clinical trial?
Frequently Asked Questions
To which patient population is this clinical trial available?
"This trial is accepting 20 participants with Huntington's Disease, ranging from 18 to 75 years old. To be considered for the study, candidates must have a score of at least 5 on the Pittsburgh Sleep Quality Index (PSQI), not changed any medications in the last month and possess sufficient mental capacity to make an informed decision about participation."
How many participants is this clinical trial recruiting?
"Indeed, according to clinicaltrials.gov this medical trial is still accepting patients for recruitment. The study was initially published on January 22nd 2021 and was most recently updated on May 23rd 2022. It requires 20 participants from a single location to complete the research project."
Does this investigation permit the participation of individuals aged over 35?
"This trial has a relatively broad age requirement of 18 to 75 years old. 34 studies are targeting applicants below the legal age and 127 focus on senior citizens above 65."
Are there any slots available for recruitment in this clinical investigation?
"According to the clinicaltrials.gov, this medical study is currently enrolling patients; it was initially announced on January 22nd 2021 and had its most recent update approved on May 23rd 2022."